Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
52.68
-1.27 (-2.35%)
At close: Jul 22, 2026, 4:00 PM EDT
52.41
-0.27 (-0.51%)
Pre-market: Jul 23, 2026, 7:52 AM EDT

TG Therapeutics Revenue

TG Therapeutics had revenue of $204.92M in the quarter ending March 31, 2026, with 69.56% growth. This brings the company's revenue in the last twelve months to $700.35M, up 81.26% year-over-year. In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth.

Revenue (ttm)
$700.35M
Revenue Growth
+81.26%
P/S Ratio
10.66
Revenue / Employee
$1,755,261
Employees
399
Market Cap
7.47B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025616.29M287.28M87.32%
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019152.00K--
Dec 31, 2018152.00K--
Dec 31, 2017152.00K--
Dec 31, 2016152.00K-381.00-0.25%
Dec 31, 2015152.38K--
Dec 31, 2014152.38K--
Dec 31, 2013152.38K133.33K699.98%
Dec 31, 201219.05K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ionis Pharmaceuticals1.06B
Mirum Pharmaceuticals569.61M
Rhythm Pharmaceuticals217.17M
ImmunityBio140.98M
Protagonist Therapeutics74.06M
Crinetics Pharmaceuticals18.07M
Praxis Precision Medicines7.46M
Revenue Rankings

TGTX News

More News